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Abstract: Oligonucleotides carrying thiol groups are useful intermediates for a remarkable 
number of applications involving nucleic acids. In this study, DNA oligonucleotides 
carrying tert-butylsulfanyl (t-BuS) protected thiol groups have been prepared. A building 
block derived from threoninol has been developed to introduce a thiol group at any 
predetemined position of an oligonucleotide. The resulting thiolated oligonucleotides have 
been used for the preparation of oligonucleotide conjugates and for the functionalization of 
gold nanoparticles using the reactivity of the thiol groups. 
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1. Introduction 
Modified oligonucleotides containing thiol groups are being used profusely in several fields and 
especially in the DNA nanobiotechnology field. Thus, thiolated oligonucleotides were first synthesized 
to facilitate the introduction of biotin, fluorescent compounds and other nonradioactive labels [1,2]. 
Later, thiolated oligonucleotides were used to produce oligonucleotide-peptide conjugates using  
post-synthetic protocols [3,4] and oligonucleotide-protein conjugates [5–7]. The preparation of 
conformationally restricted DNA structures were achieved by crosslinking thiolated oligonucleotides 
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by disulfide bond formation [8,9]. More recently, thiolated oligonucleotides were used for the 
immobilization of DNA onto gold surfaces [10–12] and the preparation of DNA-functionalized gold 
nanoparticles [13–16]. 
We are interested in the incorporation of thiol groups into two-dimensional DNA lattices [17] by 
introducing a single thiol group per DNA unit. Thiol groups have a strong affinity for gold surfaces 
and as well they can be used for the introduction of non-radioactive labels and peptides functionalized 
with maleimido or iodo- or bromoacetamide groups. Previous work has demonstrated that 
bidimensional DNA arrays carrying thiolated nucleobases at the apex of the topological markers can 
be deposited on gold surfaces [17] or reacted with the appropriate maleimido derivatives to generate 
functionalized DNA bidimensional arrays [18,19]. We become interested in the preparation of similar 
building blocks using an inexpensive non-nucleoside residue as starting material. Here, we describe a 
straightforward synthesis of a threoninol derivative carrying the (t-butyldisulfanyl)ethyl group which 
allows the introduction of a protected thiol group at any position of an oligonucleotide. The utility of 
the new derivative is demonstrated with the preparation of several oligonucleotide conjugates using the 
specific reactivity of the thiol group. 
2. Results and Discussion 
2.1. Synthesis of the Threoninol Derivatives Needed for Oligonucleotide Synthesis 
In order to incorporate functional groups at any predetermined position of oligonucleotides it is 
convenient to select a building block with two hydroxyl groups which would allow the use of the 
phosphoramidite strategy developed for the synthesis of oligonucleotides. We selected an acyclic 
scaffold such as L-threoninol to incorporate a 3-mercaptopropionic acid derivative conveniently 
protected with a tert-butylsulfanyl group [4,9,20] into DNA as depicted in Scheme 1. Threoninol has 
been used previously to introduce several units such as Methyl Red moieties [21], photoactive 
azobenzenes [22], DNA-binding drugs [23] and tetrathiafulvalene derivatives [24,25] into 
oligonucleotides. Recently, siRNA derivatives carrying aromatic groups linked through threoninol at 
their 3'-end were prepared to modulate the binding of a passenger strand to the RISC complex [26]. 
The tert-butylsulfanyl group [4,9,20] was selected for the protection of the thiol group.  
Other groups such as the S-trityl [1], acetyl [27], benzoyl [28], 2,4-dinitrophenylethyl [29],  
N-trifluoroacetamidoethylsulfanyl [30] and 2-nitrobenzyl [31] have been described for the preparation 
of thiolated oligonucleotides. We selected this protecting group because is compatible with the 
oligonucleotide synthesis conditions and can be removed in the presence of reducing agents 
independently of the final ammonia deprotection. 
3-Mercaptopropionic acid was reacted with di-tert-butyl 1-(tert-buylthio)-1,2-hydrazine-
dicarboxylate [20] to yield the t-BuS-protected derivative 1. The amino group of threoninol was 
reacted with the t-BuS-protected 3-mercaptopropanoic acid derivative yielding the threoninol amide 2 
(Scheme 1). Then, the primary hydroxyl group was protected with the 4,4'-dimethoxytrityl (DMT) 
group. Finally, the secondary alcohol was used to prepare either the phosphoramidite 6 or the 
hemisuccinate 4. The hemisuccinate was further used to functionalize controlled pore glass (CPG) 
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solid support (5). Derivatives 5 and 6 were used for the assembly of oligonucleotides using solid-phase 
methods [25,26]. 
Scheme 1. Synthesis of the phosphoramidite and functionalized solid support needed for 
the synthesis of oligonucleotides bearing thiol groups. 
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Reagents and conditions: (a) Di-tert-butyl-1-(tert-buthylthio)-1,2-hydrazinecarboxylate, 
triethylamine, DMF; (b) L-threoninol, EDCI, 1-hydroxybenzotriazole, diisopropylethylamine, 
DMF; (c) dimethoxytrityl chloride, pyridine; (d) succinic anhydride, N,N-dimethylaminopyridine, 
pyridine; (e) long chain amino alkyl-controlled pore glass (LCAA-CPG), TBTU, triethylamine, 
ACN; (f) 2-cyanoethyl-N,N-diisopropylaminochlorophosphine, diisopropylethylamine, CH2Cl2. 
2.2. Oligonucleotide Synthesis 
Oligonucleotide sequences (Table 1) carrying the disulfide group at 3' and 5'-ends as well as in 
internal positions were assembled using the appropriate chemicals including the solid support 5 and 
phoshoramidite 6. Previous work described the oxidation of the t-BuS group on a 5-methylcytidine 
derivative when standard iodine solution was used [19]. This side reaction yielded sulfonic acid 
derivatives and it was minimized by replacing the commercially available iodine solution used for the 
phosphite oxidation by a tert-butyl hydroperoxide solution [19]. For this reason we first analyzed the 
effect of both solutions on the stability of the disulfide moiety. Then two syntheses of oligothymidine 
7 were carried out. One was achieved using a 10% tert-butyl hydroperoxide solution in ACN and the 
other one using the standard 0.02 M iodine solution. Figure 1 shows the HPLC profiles obtained after 
ammonia cleavage (1 h, room temperature). In both cases a main peak was observed (tR = 8.0 min), 
which was collected and characterized by mass spectrometry, corresponding to oligonucleotide 7.  
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In addition some extra peaks between 4–6 min were observed in the HPLC profiles, especially when 
the tert-butyl hydroperoxide solution was used as oxidant. These products were assigned to 
degradation products deriving from the oxidation of the t-BuS group to sulfonic acids [19] although we 
could not obtain a clear mass spectrum from this HPLC fraction. We concluded that the best result was 
obtained when the iodine solution was used as oxidant. For this reason, standard iodine oxidation 
conditions were used for the preparation of the rest of the DNA sequences (Table 1). 
Table 1. Oligonucleotide sequences prepared in this study. 
# Sequence (5'-3') 1 
HPLC 
(min) 2 
MS, 
(expected) 
MS, 
[M−H]− (found) 
7 TTTTTTTTTTTT-X(t-Bu) 8.5 3,931.6 3,931.4 
8 AAAAGGGCAAGG-X(t-Bu) 8.0 4,095.7 4,093.1 
9 TTCCA-X(t-Bu)-ATTACCG 6.5 3,923.6 3,925.4 
10 X(t-Bu)-ACTATCCAGGAAA 7.7 4,005.7 4,004.6 
11 CTGTTGGCTT-X(t-Bu)-TGCCAACAG 6.1 3 6,134.0 6,132.8 
12 
GCAGTCGCACGACCTGGCGTCTGTTGGCTT-X 
(t-Bu)-TGCCAACAGTTTGTACTACGCAATCC 
TGCCGTATCGACG 
6.3 3 21,513.9 A−12: 1,792.9 4 
13 CGGAGGTACATTCGACTTGA-X(t-Bu) 7.8 6,496.0 6,487.3 
14 Fluoresceine-CGGAGGTACATTCGACTTGA-X(t-Bu) 6.1 7,019.0 7,023.8 
15 AAAAGGGCAAGG-X 4.5 4,007.6 3,995.6 
16 AAAAGGGCAAGG-X(Nan) 5.9 4,201.8 4,207.9 
17 AAAAGGGCAAGG-X(Py) 
10.8, 
11.0 
4,302.9 4,307.8 
18 TTTTTTTTTTTT-X 5.4 n.d. n.d. 
19 TTTTTTTTTTTT-X(Nan) 6.6 4,037.7 4,041.4 
20 CGGAGGTACATTCGACTTGA-X 4.7 n.d. n.d. 
21 Fluoresceine-CGGAGGTACATTCGACTTGA-X 5.6 n.d. n.d. 
1 X(t-Bu) = N-[2-(tert-butyldisulfanyl)ethylcarbonyl]-L-threoninol; X = N-(mercaptoethyl-
carbonyl)-L-threoninol; X(Nan) = 2-hydroxy-5-nitroacetaniline derivative; X(Py) = Pyrenyl 
maleimido derivative (see Scheme 2). The underlined bases in sequences 11 and 12 are involved in 
the formation of the hairpin; 2 Retention time values obtained in the HPLC analysis (see conditions 
in experimental part); 3 Temperature of the HPLC column was 60 °C to avoid secondary structures;  
4 mass measured from the M12− by electrospray (Synapt HDMS system); n.d.: not determined. 
Oligonucleotides 7 and 8 bearing the disulphide group at the 3'-end position were prepared using 
the functionalized solid support 5. The phosphoramidite 6 was used to prepare oligonucleotides 9 and 
10 carrying the disulfide moiety in the middle of the sequence and at the 5'-end position respectively. 
In all cases the modified oligonucleotides 7–10 were obtained as the major compounds (Figure S1, 
supplementary information). The main products were collected and analyzed by mass spectrometry 
(MALDI-TOF). The results are summarized in Table 1. In addition to the expected compound we have 
observed the presence of variable amounts of side compounds with shorter retention time (tR around  
4 min). When oligonucleotide 7 (prepared with iodine) was treated with the ammonia solution for 
several hours at 55 °C we observed as well the presence of these side products in the HPLC profiles 
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(data not shown). Then we reasoned that these side compounds are related with the ammonia treatment 
required for the cleavage and deprotection of nucleobases and phosphate groups. We observed as well 
that the extension of the side reaction depended on the position where the modified residue was placed. 
For instance, the amount of these side products detected in the HPLC profile of crude compound 9 
(threoninol derivative located in the middle of the sequence), represented less than 5%. On the other 
hand, HPLC profiles of crude oligonucleotides 8 and 10 (threoninol derivative attached at the ends of 
each sequence) showed higher amounts (15–25%). MS analysis of the main side compound showed 
the loss of 104 mass units from the expected molecular mass. We hypothesized that this loss may be 
due to the removal of the t-BuSS group (121 mass units) and to the subsequent addition of a NH2 
group. This compound may be formed by direct nucleophilic displacement of the t-BuSS group or by  
β-elimination of the t-BuSS group followed by ammonia addition to the resulting olefin (Scheme S1, 
supplementary information). This side reaction was produced when the treatment with ammonia was 
extended to 12 h at 55 °C for the removal of the isobutyryl group of guanine and it was mainly 
observed in oligonucleotides carrying the disulfide group at terminal positions. The use of milder 
protecting groups for guanine such as dimethylformamidino group may help to avoid the elimination 
of the t-BuSS group. 
Figure 1. HPLC profiles of crude oligonucleotide 7 using different oxidants: (A) 10%  
tert-butyl hydroperoxide solution in ACN and (B) standard 0.02 M iodine solution. In both 
cases ammonia cleavage was performed at r. t. for 1 h.  
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Next we synthesized two long hairpin oligonucleotides 11,12 carrying one disulfide group in the 
middle of the loop (Table 1, Scheme 2). Oligonucleotide 12 corresponds to one of the five 
oligonucleotides described by the group of Seeman for the preparation of bidimensional DNA arrays 
by the “tile system” [32]. Specifically this sequence carries a topological marker in the form of a 
protruding DNA hairpin which has been used to incorporate thiol groups able to anchor bidimensional 
DNA arrays into gold surfaces [17]. Oligonucleotide 11 corresponds to the protruding hairpin  
part of oligonucleotides 12 without the single-stranded parts which pair with the corresponding 
complementary sequences designed to form a DNA tile. Both thiolated oligonucleotides were prepared 
using the phosphoramidite derivative 6 obtaining the desired compounds. The characterization of 
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oligonucleotide 12 was carried out by electrospray mass spectrometry (Synapt HDMS system,  
Waters-Micromass). The molecular mass of such a long oligonucleotide was obtained from the  
A−12 (1,792.9) and A−11 (1,958.5) ions. 
Finally we have prepared oligonucleotides 13 and 14. These oligonucleotides are 20 mer that will 
be used for the functionalization of gold nanoparticles. Both oligonucleotides have the same DNA 
sequence and carry the threoninol derivative at the 3'-end but, in addition, oligonucleotide 14 bears a 
fluoresceine derivative at the 5'-end to quantify the degree of functionalization of the resulting 
nanoparticles. Both oligonucleotides were obtained in good yields. Additionally, we cleaved the t-BuS 
group of both disulphide oligonucleotides to obtain the corresponding thiol oligonucleotides 20 and 21. 
Preparing both disulfide and thiol analogues allow for comparison of stability and surface coverage of 
the resulting conjugates. For comparison purposes we have also prepared the 20-mer oligonucleotide 
sequences carrying the commercially available 3'-thiol modifier (see Supplementary Information). 
Scheme 2. Structures of the threoninol derivatives prepared in this study. The broken lines 
indicate H or the oligonucleotide chain. 
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2.3. Denaturation Studies on Duplexes Carrying the Tert-Butylsulfanyl Threoninol Derivative 
In order to assess the influence of the threoninol derivative in the duplex structure, we performed 
melting experiments with the modified oligonucleotides 8, 9 and 10. Table 2 shows the melting 
temperatures of several duplexes carrying the tert-butylsulfanyl protected threoninol derivative and the 
corresponding non modified duplexes. As expected, the presence of the threoninol derivative either at 
the 3'-end (entry 1) or at the 5'-end (entry 3) of a duplex had very little effect in the stability compared 
with the corresponding non modified duplex (entries 2 and 4 respectively). The comparison of entries 
4 and 5 indicates that the introduction of the tert-butylsulfanyl protected threoninol derivative in the 
middle of the DNA sequence induces a remarkable destabilizing effect (6.3 °C).  
Finally the effect of the modification placed in the middle of the loop of the hairpin 11 was studied. 
To this end, an unmodified version of the hairpin was synthesized replacing the threoninol derivative 
by a thymidine. The melting temperatures obtained from the denaturation curves were very similar in 
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both cases (entries 7 and 8). Then we conclude that the presence of the threoninol derivative in the 
loop do not induce any significant change in the denaturation process of the hairpin. 
Table 2. Melting temperatures of duplexes carrying the tert-butylsulfanyl threoninol derivative. 
Entry Duplex Tm (°C) Tm (°C) 
1 5'-AAAAGGGCAAGG-X(t-Bu)-3' (8)/3'-TTTTCCCGTTCC-5' 52.3 1 −0.7 
2 Unmodified 5'-AAAAGGGCAAGG-3'/3'-TTTTCCCGTTCC-5' 53.0 1 -- 
3 5'-X(t-Bu)-ACTATCAGGAAA-3' (10)/3'-TGATAGTCCTTT-5' 43.9 1 +0.5 
4 Unmodified 5'-ACTATCAGGAAA-3'/3'-TGATAGTCCTTT-5' 43.4 1 -- 
5 5'-TTCCA-X(t-Bu)-ATTACCG-3' (9)/3'-AAGGTTAATGGC-5' 42.2 1 −6.3 
6 Unmodified 5'-TTCCAATTACCG-3'/3'-AAGGTTAATGGC-5' 48.5 1 -- 
7 Hairpin 5'-CTGTTGGCTT-X(t-Bu)-TGCCAACAG-3' (11) 75.2 2 −0.2 
8 Unmodified hairpin 5'-CTGTTGGCTTTTGCCAACAG-3' 75.4 2 -- 
1 Conditions: 0.3 M NaCl, 10 mM phosphate buffer pH 7.0; 2 conditions: 50 mM NaCl, 10 mM 
phosphate buffer pH 7.0; Tm is the difference in Tm between the non modified duplex and the 
corresponding modified duplex. The underlined bases in sequence 11 are involved in the formation 
of the hairpin. 
2.4. Functionalization of Thiol Oligonucleotides 
Oligonucleotides bearing thiol groups are important intermediates for the introduction of 
fluorescent compounds and other non-radioactive labels into oligonucleotides [1,2]. To this end, we 
studied the preparation of oligonucleotide conjugates by reaction of the thiolated oligonucleotides with 
maleimido and 2-bromoacetamide compounds. Oligonucleotides 7 and 8 were used to perform 
reactions with N-(1-pyrenyl)maleimide and 2-bromo-2'-hydroxy-5'-nitroacetaniline. The first step 
consisted in the cleavage of the t-BuS group. An aqueous solution of oligonucleotide 8 was treated 
with a solution of tris(2-carboxyethyl)phosphine (TCEP) at 55 °C. The removal of the t-BuS group 
was monitored by HPLC (Figure S4, supporting information). Under these conditions the complete 
deprotection of the thiol was achieved in four hours. The resulting oligonucleotide 15 was isolated and 
characterized by mass spectrometry (Table 1). 
Then, oligonucleotide 15 was reacted either with 2-bromo-2'-hydroxy-5'-nitroacetaniline and  
N-(1-pyrenyl)maleimide overnight. Both conjugates (16 and 17) were obtained in good yields, ranging 
from 80 to 85% as depicted in Figure 2 (conjugation yields were determined by HPLC analysis of the 
crudes). In both cases the main compounds were collected and analyzed by mass spectrometry. The 
results are summarized in Table 1. The reaction with N-(1-pyrenyl)maleimide yielded two main 
products (Figure 2B) sharing the same mass once analyzed by mass spectrometry. These compounds 
may correspond to the two possible isomers coming from the reaction of the thiol group with the 
maleimide group. 
A conjugation assay was performed as well with the oligothymidine thiol sequence. 
Oligonucleotide 7 once treated with a TCEP solution yielded the deprotected oligonucleotide 18, 
which was reacted with 2-bromo-2'-hydroxy-5'-nitroacetaniline. The desired conjugate 19 was obtained in 
good yield (81%, conjugation yield was determined by HPLC analysis of the crude, Figure S5 
supplementary information). 
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Figure 2. HPLC profiles of the mixtures obtained after the reaction of oligonucleotide 15 
with (A) 2-bromo-2'-hydroxy-5'-nitroacetaniline to yield compound 16 and (B) with  
N-(1-pyrenyl)maleimide to yield compound 17. (▼ stands for the thiol oligonucleotide 15 
and ♦ stands for the resulting oligonucleotide conjugates). 
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2.5. Nanoparticle Functionalization and Stability Measures 
We studied as well the functionalization of gold nanoparticles with thiolated oligonucleotides. For 
this purpose, oligonucleotide 13, carrying a disulfide modification at the 3'-end was prepared. The thiol 
oligonucleotide (compound 20) was prepared by treating oligonucleotide 13 with TCEP as described 
above. Immobilization of the thiolated oligonucleotides on 10 nm citrate-reduced gold nanoparticles 
was carried out using standard protocols [33]. The resulting functionalized gold nanoparticles were 
characterized by UV-vis spectroscopy (Figure 3A). After modification only a small shift in the surface 
plasmon band was observed (λmax 519 to 525 for 13-AuNp and λmax 519 to 522 for 20-AuNp). The 
effect of the disulfide and thiol modified oligonucleotides on the stability of the conjugates was 
investigated following procedures described in the literature [34,35]. Each conjugate were treated with 
DTT (10 mM) at 40 °C and left to aggregate and the UV-vis spectra were recorded at 1 min interval 
(Figure 3B,C). Stability was evaluated by measuring the increment of absorbance at 675 nm that 
resulted from gold nanoparticle aggregation (Figure 3D). The half-time t1/2 (the time required to reach 
half the value for complete aggregation) was calculated from the curves. This parameter was 
determined by taking the midpoint in the absorbance change at 675 nm as a function of time. For 
conjugates obtained with oligonucleotide 13 (13-AuNp) the t1/2 was less than 2 min and for the 
conjugates obtained with oligonucleotide 20 (20-AuNP) the half-life was around 16 min (Table 3). The 
result obtained for 13-AuNp is in good agreement with other gold nanoparticle conjugates 
functionalized with commercially available disulfide oligonucleotides [35]. Conjugation of AuNp with 
the 20-mer functionalized with the commercial 3'-thiol modifier gave similar results (supplementary 
information). Moreover, we found some discrepancies when we compared the stability results obtained 
for 20-AuNp with other gold nanoparticle conjugates functionalized with commercially available 
alkanethiol oligonucleotides [34,35]. In our opinion, these discrepancies may be attributed to 
methodological differences that we introduced to obtain our conjugates. In our case the saline 
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concentration of the buffers we used was lower (we used 0.15 M NaCl instead of 0.30 M NaCl). The 
other aspect to consider is the compound we used for the disulfide reduction (we used TCEP instead of 
DTT). In any case, the gold nanoparticles resulting from the reaction with thiol-oligonucleotide 20 
under our experimental conditions have higher stability to DTT solutions than the gold nanoparticles 
resulting from the reaction with disulfide oligonucleotide 13. 
Figure 3. (A) UV-vis spectra of the initial gold nanoparticle solution and the 
functionalized gold nanoparticles with oligonucleotides 13 and 20. Time evolution of  
UV-Vis spectra of gold nanoparticle conjugates in 10 mM DTT. (B) Disulfide 
oligonucleotide 13. (C) Thiol oligonucleotide 20. (D) Absorbance changes monitored with 
time at 675 nm for both conjugates. 
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The degree of functionalization of gold nanoparticles conjugates was investigated using the 
fluoresceine-labelled oligonucleotides 14 and 21 (disulfide and thiol oligonucleotide, respectively) 
following a method described by Mirkin et al. [35,36]. The resulting functionalized gold nanoparticles  
14-AuNp and 21-AuNp were characterized by UV-vis spectroscopy (Figure S6A, Supplementary 
Information). After functionalization only a small shift in the surface plasmon band was observed  
(max 519 to 522 for both conjugates). Aliquots of 14-AuNp and 21-AuNp were treated with a DDT 
solution at room temperature for two hours. The surface coverage was obtained from the fluorescent 
intensity of the released oligonucleotides. By measuring the concentration of oligonucleotides and gold 
nanoparticle conjugates of each sample (three times, two sets of samples), an average number of 
oligonucleotides per particle was calculated (Table 3). It was found that 14-AuNp has less surface 
coverage (~37 pmol/cm2) than the thiol oligonucleotide-gold nanoparticle conjugate 21-AuNp  
(~54 pmol/cm2). Conjugation of AuNp with the 20-mer functionalized with the commercial 3'-thiol 
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modifier gave similar results (supplementary information). The results obtained are in the range  
of thiol oligonucleotides-gold nanoparticle conjugates commercially available described in the 
literature [32,33,35–37]. We registered as well the fluorescence spectra of a functionalized gold 
nanoparticle sample (14-AuNP) before treatment with DTT and the fluorescence intensity of the 
released oligonucleotides once the sample was treated with DTT (Figure S6B, Supporting 
Information). Comparing both spectra we observed that the fluorescence from the bounded 
oligonucleotides was quenched by more than 98% by the gold nanoparticles.  
Table 3. Half-lives and surface coverage data for oligonucleotide-gold nanoparticle conjugates. 
Conjugate name t1/2 (min) 
Surface coverage 
Strands/particle pmol/cm2 
13-AuNp 1.8 ---- ---- 
20-AuNp 14.5 ---- ---- 
14-AuNp ---- 63.0 ± 4.1 37.4 ± 2.8 
21-AuNp ---- 97.4 ± 6.8 53.9 ± 5.5 
Finally, hairpin oligonucleotide (11) carrying one disulfide group in the middle of the loop was 
deprotected with TCEP (55 °C, o.n.) and the resulting thiol-oligonucleotide was reacted with 10 nm 
citrate-stabilized AuNp. The resulting functionalized AuNps were characterized by UV-vis 
spectroscopy, showing similar properties to the AuNp obtained with 5'- or 3'-thiolated oligonucleotides 
(Supplementary Information). This result shows the usefulness of the new thiol reagent developed in 
this work allowing the functionalization of AuNp of hairpin oligonucleotides using the loop positions. 
These interesting functionalized nanoparticles can not be produced with commercially available reagents. 
3. Experimental 
3.1. General 
All reagents were purchased from Sigma-Aldrich or Fluka and were used without further 
purification. Dry solvents were purchased as well from Sigma-Aldrich or Fluka and used as supplied. 
All the standard phosphoroamidites and ancillary reagents used for oligonucleotide synthesis were 
purchased from Applied Biosystems or Link Technologies. Flash column chromatography was carried 
out on silica gel SDS 0.063–0.2 mm/70–230 mesh. 
1H- and 13C-NMR spectra were recorded at 25 °C on a Varian Mercury 400 MHz spectrometer and 
the 31P-NMR spectra were recorded on a Varian Inova 300 MHz spectrometer using CDCl3. 
Tetramethylsilane (TMS) was used as an internal reference (0 ppm) for 1H spectra and the residual 
signal of the solvent (77.16 ppm) for 13C and 31P. Chemical shifts are reported in part per million 
(ppm) in the δ scale, coupling constants in Hz and multiplicity as follows: s (singlet), d (doublet),  
t (triplet), q (quadruplet), m (multiplet), br (broad signal). HPLC separations were performed using a 
Waters 2695 Separations Module with a Waters 2998 Photodiode Array Detector. UV analyses and 
melting curves were performed using a Jasco V-650 instrument equipped with a thermoregulated cell 
holder. Fluorescent measures were performed using a Jasco FP-6200 spectrofluorometer as well 
equipped with a thermoregulated cell holder. Electrospray ionization mass spectra (ESI-MS) of 
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compounds 1–3 and 6 were recorded on a Micromass ZQ instrument with single quadrupole detector 
coupled to a Waters Alliance 2696 HPLC. Matrix-assisted laser desorption ionization time-of-flight 
(MALDI-TOF) mass spectra of oligonucleotides were recorded either on a Voyager-DETM RP 
spectrometer (Applied Biosystems) or in a Perseptive Biosystems Voyager DE-RP instrument 
(Applied Biosystems) in negative mode by using 2,4,6-trihydroxyacetophenone (THAP)/ammonium 
citrate (1:1) (THAP-CA as matrix and additive respectively). The mass spectra analysis of 
oligonucleotide 12 was performed in the negative ion mode on Synapt G1 HDMS travelling wave ion 
mobility mass spectrometer (Waters-Micromass). The experiment was performed using a 384 well 
plate and introduced by automated chip-based nanoelectrospray using a Triversa NanoMate  
(Advion BioSciences). 
3-(tert-Butyldisulfanyl)propanoic Acid (1). A solution of 3-mercaptopropanoic acid (0.34 mL,  
3.9 mmol) and triethylamine (1.1 mL 7.8 mmol) in anhydrous dimethylformamide (DMF) (15 mL) 
was prepared under argon. Di-tert-butyl-1-(tert-butylthio)-1,2-hydrazinedicarboxylate (2.5 g 7.8 mmol) 
was dissolved in anhydrous DMF (10 mL) and added dropwise to the stirred solution. The reaction 
mixture was stirred at room temperature overnight, and the reaction was complete as judged by TLC. 
The solvent was evaporated under reduced pressure. In order to remove the remaining DMF, the 
residue was dissolved in toluene and evaporated under reduced pressure. The procedure was repeated 
three times. We used two different methodologies to purify the carboxylic acid. Method 1: The 
resulting crude was dissolved with 100 mL 10% aqueous solution of sodium hydroxide and washed 
three times with 50 mL of hexane. The aquerous solution was acidified with hydrochloric acid fuming 
37% until pH = 2–3, and then was extracted with 50 mL of ethyl acetate (×3). The extracts were 
combined, dried over MgSO4 and concentrated to dryness under reduced pressure. The desired product 
(pale yellow oil) was obtained with 57% yield (0.36 g). Method 2: The product was purified by 
chromatography on silica gel. The column was packed with silica gel using a 1% triethylamine 
solution in ethyl acetate. The byproducts were eluted with a gradient of ethyl acetate to ethyl 
acetate/methanol 100:10. Then, the product was eluted using a 1% acid acetic solution in ethyl 
acetate/methanol 100:10. The pure fractions were combined and the solvent was eliminated under 
reduced pressure. The resulting residue was dissolved with 100 mL of ethyl acetate and the organic 
phase was washed with 50 mL of water and 50 mL of a saturated NaCl aqueous solution. The organic 
phase was dried over anhydrous magnesium sulphate and concentrated to dryness under reduced 
pressure. The desired product (pale yellow oil) was obtained with 34% yield (0.26 g). TLC (ethyl 
acetate) Rf = 0.35; 1H-NMR, H (CDCl3): 2.92 (t, J = 7 Hz, 2H), 2.78 (t, J = 7 Hz, 2H), 1.34 (s, 9H); 
13C-NMR, C (CDCl3): 178.20 (CO), 48.27 (C), 34.58 (CH2), 34.26 (CH2), 30.16 (CH3); ESI-MS m/z 
(negative mode) [M−H]− = 193.04, (M = 194.04 g/mol calculated for C7H14O2S2). 
N-[2-(tert-Butyldisulfanyl)ethylcarbonyl]-L-threoninol (2). A solution of compound 1 (300 mg,  
1.54 mmol), L-threoninol (162 mg, 1.54 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDCI) (413 mg, 2.31 mmol), hydroxybenzotriazole (HOBt) (313 mg, 2.31 mmol), and  
N,N-diisopropylethylamine (0.40 mL, 2.31 mmol) in anhydrous DMF (15 mL) was prepared under 
argon. After stirring the reaction mixture at room temperature overnight, the reaction was complete as 
judged by TLC and then concentrated to dryness under reduced pressure. In order to remove the 
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remaining DMF, the residue was dissolved in toluene and concentrated to dryness under reduced 
pressure (×3). The residue was dissolved in 100 mL of dichloromethane (DCM) and the organic phase 
was washed with 50 mL 10% NaCO3H aqueous solution (×2) and 50 mL of a saturated NaCl aqueous 
solution. The organic phase was dried over anhydrous magnesium sulphate and concentrated to 
dryness under reduced pressure. The pure compound was obtained as a white solid (346 mg, 80% 
yield). TLC (ethyl acetate) Rf = 0.19. 1H-NMR, H (CDCl3): 6.41 (d, J = 6.8 Hz, 1H), 4.19 (qd,  
J = 6.4 and 1.6 Hz, 1H), 3.88–3.82 (m, 3H), 2.98 (t, J = 7.0 Hz, 2H), 2.66 (t, J = 7.0 Hz, 2H), 1.34 (s, 
9H), 1.23 (d, J = 6.4 Hz, 3H). 13C-NMR, C (CDCl3): 172.23 (CO), 68.72 (CH), 64.86 (CH2),  
55.12 (CH), 48.47 (C), 36.25 (CH2), 35.82 (CH2), 30.18 (CH3), 20.71 (CH3). ESI-MS m/z (positive 
mode) [M+H]+ = 282.13, (M = 281.11 g/mol calculated for C11H23NO3S2). 
O1-(4,4'-Dimethoxytriphenylmethyl)-N-[2-(tert-butyldisulfanyl)ethylcarbonyl]-L-threoninol (3). Compound 
2 (242 mg, 0.86 mmol) was dried by evaporation of anhydrous acetonitrile (ACN) under  
reduced pressure and then dissolved in anhydrous pyridine (10 mL) under argon.  
4,4'-Dimethoxytriphenylmethyl chloride (320 mg, 0.94 mmol) was added with stirring and exclusion 
of moisture, and the reaction was allowed to proceed at room temperature overnight. Then the reaction 
was quenched with methanol (0.5 mL). The solvent was removed under reduced pressure, and the 
residue was dissolved in DCM (75 mL). The organic phase was washed with 5% aqueous NaCO3H 
solution (30 mL) and with saturated NaCl solution (30 mL). The organic phase was dried over 
anhydrous magnesium sulphate and filtered. After filtration and removal of the solvent under reduced 
pressure, the product was purified by chromatography on silica gel. The column was packed with silica 
gel using a 1% triethylamine solution in ethyl acetate/hexane 1:1. The product was eluted with a 
gradient of hexane/ethyl acetate (1:1) to 100% ethyl acetate. The pure compound was obtained as 
white foam (309 mg, 62%). TLC (ethyl acetate/hexane 2:1) Rf = 0.35. 1H-NMR, H (CDCl3):  
7.39–6.83 (m, 13H), 6.16 (d, J = 8.8 Hz, 1H), 4.07 (qd, J = 6.4 Hz and 1.6 Hz, 1H), 3.95–3.91 (m, 1H), 
3.79 (s, 6H), 3.44 (dd, J = 9.6 Hz and 4.2 Hz, 1H), 3.28 (dd, J = 9.6 Hz and 3.2 Hz, 1H), 2.99–2.95 (m, 
2H), 2.64–2.61 (m, 2H), 1.34 (s, 9H), 1.13 (d, J = 6.4 Hz, 3H). 13C-NMR, C (CDCl3): 171.39 (CO), 
158.87 (CH), 158.86 (CH), 144.54 (C), 135.69 (C), 135.50 (C), 130.14 (CH), 128.26 (CH),  
128.15 (CH), 127.26 (C), 113.56 (CH), 87.07 (C), 68.91 (CH), 65.52 (CH2), 55.46 (CH3), 53.64 (CH),  
48.33 (C), 36.33 (CH2), 35.73 (CH2), 30.20 (CH3), 20.13 (CH3). ESI-MS m/z (negative mode)  
[M−H]− = 582.24, (M = 583.24 g/mol calculated for C32H41NO5S2). 
3.2. Synthesis of CPG Support 5 Functionalized with Compound 3  
Compound 3 was incorporated on a long-chain alkylamine-controlled pore glass support  
(LCAA-CPG) following the standard methodology using the hemisuccinate derivative 4. Compound 3 
(50 mg, 0.09 mmol) was dried by evaporation of anhydrous ACN under reduced pressure. Then, 
compound 3 was dissolved in anhydrous pyridine (5 mL) under argon. Succinic anhydride (21 mg, 
0.21 mmol) and 4-dimethylaminopyridine (DMAP) (6 mg, 0.05 mmol) were added to the solution. 
After four hours of magnetic stirring at room temperature, the reaction was complete as judged by TLC 
(5% methanol in ethyl acetate, Rf = 0.10). The solvent was removed under reduced pressure and the 
residue was dissolved in dichloromethane (20 mL). The solution was washed with saturated aqueous 
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sodium chloride (15 mL). After drying the organic phase with magnesium sulphate and filtered, the 
solvent was evaporated under reduced pressure. The monosuccinate derivative 4, which was used in 
the next step without further purification, was obtained as a white foam. 
Commercial LCAA-CPG (CPG Inc., Lincoln Park, NJ, USA, 300 mg, 73 µmol amino/g) was 
placed into a polypropylene syringe fitted with a polypropylene disc and washed sequentially with 
DMF, methanol, THF, DCM, and ACN. Then, a solution of O1-(4,4'-dimethoxytriphenylmethyl)-N-[2-
(tert-butyldisulfanyl)ethyl-carbonyl]-O3-(succinyl)-L-threoninol (4) (28 mg 0.045 mmol) and 
triethylamine (26 µL, 0.36 mmol) in 0.5 mL of anhydrous ACN was prepared. The solution was  
added to the resin and then a solution of 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
tetrafluoroborate (TBTU) (59 mg 0.36 mmol) in 0.3 mL of anhydrous ACN was incorporated to the 
mixture and left to react for 30 min. The resin was washed with DMF, methanol, DCM and ACN. The 
incorporation of compound 4 was determined by DMT quantification. The coupling procedure was 
repeated once more time and the functionality of the resin was determined by DMT quantification (f = 
22 µmol/g). Then, the resin treated with 500 µL of Ac2O/DMF 1:1 to cap free amino groups. 
O1-(4,4'-Dimethoxytriphenylmethyl)-N-[2-(tertbutyldisulfanyl)ethyl-carbonyl]-O3-[2-
cyanoethyl-N,N-diisopropylaminophosphinyl]-L-threoninol (6). Compound 3 (180 mg 0.31 mmol) 
was dried  
by evaporation of anhydrous ACN under reduced pressure. Then, compound 3 and  
N,N-diisopropylethylamine (215 µL, 1.23 mmol) were dissolved in anhydrous DCM (10 mL) under 
argon. The solution was cooled on ice and 2-cyanoethoxy-N,N'-diisopropylaminochlorophosphine  
(112 µL, 0.46 mmol) was added dropwise with a syringe. Afterward, the solution was stirred at room 
temperature for 1 h and 30 min. After this time the reaction was complete as judged by TLC. Then, 10 
mL of DCM were added and the organic layer was washed with 5% NaCO3H aqueous solution  
(20 mL) and with saturated NaCl aqueous solution (20 mL). The organic phase was dried over 
magnesium sulphate and filtered, and the solvent was evaporated under reduced pressure. The residue 
was dissolved in a small amount of ethyl acetate/hexane 1:1 and purified by chromatography on silica 
gel. The column was packed with silica gel using a 5% triethylamine solution in ethyl acetate/hexane 
1:1. The product was eluted with ethyl acetate/hexane 1:1. The pure compound was obtained as pale 
yellow foam (123 mg 56%). TLC (ethyl acetate/hexane 1:1) Rf = 0.48 and 0.38. 31P-NMR, P (CDCl3, 
81 MHz): 148.13 and 147.93, two isomers. 1H-NMR, H (CDCl3): 7.42–6.80 (m, 13H), 5.88 and 5.72 
(2d, J = 8.8 Hz and 9.2 Hz, respectively, two isomers, 1H), 4.39–4.31 (m, 1H), 4.25–4.11 (m, 1H), 
3.79 and 3.78 (2s, two isomers, 6H), 3.57–3.46 (m, 2H), 3.26–3.08 (m, 2H), 3.02–2.90 (m, 2H),  
2.60–2.55 (m, 4H), 2.41–2.36 (m, 2H), 1.32 (s, 9H), 1.25–0.99 (m, 15H). 13C-NMR, C (CDCl3): 
170.96 (C), 158.67 (CH), 145.07 and 144.99 (C, two isomers), 136.34 (C), 136.25 and 136.24 (C, two 
isomers), 130.37 (CH), 130.32 and 130.27 (CH, two isomers), 128.50 and 128.41 (CH, two isomers), 
128.00 (CH), 127.00 and 126.96 (C, two isomers), 118.04 (C), 113.33 (CH), 113.30 and 113.28 (CH, 
two isomers), 86.37 and 86.29 (C, two isomers), 69.73 and 68.96 (CH, 2d, J = 14.4 and 16.4 Hz 
respectively, two isomers), 63.16 and 62.84 (CH2, two isomers), 58.48 and 58.09 (CH2, 2d,  
J = 19.5 and 19.5 Hz, respectively, two isomers), 55.44 and 55.41 (CH3, two isomers), 54.46 and 54.16 
(CH, 2d, J = 4.9 and 6.3 Hz, respectively, two isomers), 48.25 and 48.21 (C, two isomers), 43.37 and 
43.29 (CH, 2d, J = 12.3 and 12.5 Hz, respectively, two isomers), 36.51 and 36.43 (CH2, two isomers), 
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35.90 and 35.87 (CH2, two isomers), 30.17 (CH3), 24.93 and 24.91 (CH3, 2d, J = 7.7 and 7.8 Hz, 
respectively, two isomers), 24.76 and 24.57 (CH3, 2d, J = 6.8 and 7.1 Hz, respectively, two isomers), 
20.66 and 20.53 (CH3, 2d, J = 6.9 and 6.7 Hz, respectively, two isomers), 19.85–19.79 (CH2, m,  
two isomers). ESI-MS m/z (positive mode) [M+Na]+ = 806.34, (M = 783.35 g/mol calculated  
for C41H58N3O6PS2). 
3.3. Synthesis of Oligonucleotides 
The unmodified oligonucleotides were synthesized on a DNA synthesizer (Applied Biosystems 
3400) using 200-nmol scale LV200® polystyrene supports and commercially available chemicals. The 
benzoyl (Bz) group was used for the protection of the amino group of C and A, and the isobutyryl 
(iBu) group for the protection of G. The coupling yields were >97%. The last DMT group was 
removed at the end of the synthesis. Each solid support was treated with aqueous concentrated 
ammonia at 55 °C for 12 h to cleave the products from the supports and remove the benzoyl and 
isobutyryl groups. The mixtures were filtered and ammonia solutions were concentrated to dryness. 
Unmodified oligonucleotides were desalted with Sephadex G-25 (NAP-10 column) G-25 (NAP-10 
column) and analyzed by HPLC. Column: XBridgeTM OST C18 (4.6 × 50 mm, 2.5 µm). Solvent A: 5% 
ACN in 100 mM triethylammonium acetate (TEAA) (pH = 7) and solvent B: 70% ACN in 100 mM 
TEAA (pH = 7). Flow rate: 1 mL/min. Conditions: 10 min of linear gradient from 0 to 30% B. The 
resulting oligomers were analyzed by mass spectrometry (MALDI-TOF) and UV/Vis spectroscopy (data 
not shown) and used without further purification. The yields obtained ranged from 72 to 87%. 
The oligonucleotide sequences containing the threoninol derivative at the 3'-end (7, 8, 13 and 14) 
were synthesized on a 0.5 µmol scale using the solid support 5. Oligonucleotide sequence 7 was 
prepared using a tert-butyl hydroperoxide or the standard 0.02 M iodine solution for the oxidation of 
phosphites. Because better results were obtained using the standard 0.02 M iodine solution, all 
sequences were prepared in that way. The last DMT group was removed at the end of the synthesis. 
Each solid support was treated with aqueous concentrated ammonia at 55 °C for 12 h to cleave the 
products from the supports and remove the benzoyl and isobutyryl groups, except the support coming 
form the synthesis of oligonucleotide 7 that was treated with aqueous concentrated ammonia at room 
temperature for 1 h due to the absence of base protecting groups. Work-up was similar as described 
above. Oligonucleotide 7 (synthesis performed with iodine solution) was used without further 
purification after it was desalted with Sephadex G-25 (NAP-10 column), (74% yield, 36.2 OD260). 
Compound 8, 13 and 14 were purified by HPLC on a Nucleosil 120C18 (10 μm, 200 × 10 mm) 
column. Solvent A: 5% ACN in 100 mM of TEAA (pH = 7) and solvent B: 70% ACN in 100 mM 
TEAA (pH = 7). Flow rate: 3 mL/min. Conditions: 20 min linear gradient from 0–50% B 
(oligonucleotides 8 and 13), 20 min linear gradient from 15–38% B (oligonucleotide 14). The resulting 
products were desalted with Sephadex G-25 (NAP-10 column) and analyzed by HPLC. Column: 
XBridgeTM OST C18 (4.6 × 50 mm, 2.5 μm). Solvent A: 5% ACN in 100 mM TEAA (pH = 7) and 
solvent B: 70% ACN in 100 mM TEAA (pH = 7). Flow rate: 1 mL/min. Conditions: 10 min linear 
gradient from 0–30% B, then 5 min. linear gradient from 30–100% B (oligonucleotides 7, 8 and 13),  
4 min linear gradient from 0–12% B, then 1 min linear gradient from 12–40% B, then 5 min linear 
Molecules 2012, 17 10040 
 
 
gradient from 40–45% B, then 5 min linear gradient from 45–100% B (oligonucleotide 14). After 
HPLC purification the yields obtained ranged from 32 to 48%. 
The oligonucleotide sequence 9 (threoninol modification at the 5'-end) and sequences 10–12 
(threoninol modification in the middle), were synthesized on a 200 nmol scale employing LV200® 
polystyrene supports as described above. Phosphoramidite 6 was used to incorporate the threoninol 
derivative at the 5'-end and in the middle of the corresponding oligonucleotides. The protected 
phosphoramidite was dissolved in anhydrous DCM instead of ACN to obtain a 0.1 M solution and was 
allowed to react for 300 s instead of 30 s used for an unmodified phosphoramidite. The DMT 
determination showed that the efficiency of coupling of the phosphoramidite was >90%. The last DMT 
group was removed at the end of the synthesis. Each resin was treated with aqueous concentrated 
ammonia at 55 °C for 12 h to cleave the products from the supports and remove the benzoyl and 
isobutyryl groups. In the case of oligonucleotide 12 only a small amount of the solid support was 
treated with ammonia for characterization purposes. Work-up was similar as described above. 
Oligonucleotide 9 was used without further purification after once desalted with Sephadex G-25  
(NAP-10 column), (82% yield, 18.7 OD260). Compound 10–12 were purified by HPLC on a 
XBridgeTM OST C18 semipreparative column (10 × 50 mm, 2.5 μm). Solvent A: 5% ACN in 100 mM 
TEAA (pH = 7) and solvent B: 70% ACN in 100 mM TEAA (pH = 7). Flow rate: 3 mL/min. 
Conditions: 10 min linear gradient from 0–30% B, then 5 min linear gradient 30–100% B, at room 
temperature for oligonucleotide 10 and at 60 °C for oligonucleotides 11 and 12. The resulting products 
were desalted with Sephadex G-25 (NAP-10 column) and analyzed by HPLC. Column: XBridgeTM 
OST C18 (4.6 × 50 mm, 2.5 μm) using the conditions described above except the flow rate that was  
1 mL/min. All the purified oligonucleotides were analyzed as well by mass spectrometry. After HPLC 
purification 12.9 OD260 (50% yield) of compound 10 and 14.5 OD260 (42% yield) of compound 11 
were obtained. 
3.4. Removal of StBu Group and Conjugation of the Resulting Thiol Oligonucleotides 
Oligonucleotides 7 and 8 (1–3 OD260) were dissolved in 300 μL of an aqueous solution 0.1 M 
TEAA (pH = 7). Then, 34 μL of an aqueous solution of 0.1 M TCEP were added to the solution and 
allowed to react at 55 °C. Different samples were analyzed by HPLC at different times of reaction (1 h, 
3 h and 4 h) (Figure S4, Supplementary Information). Column: X-BridgeTM OST C18 (2.5 μm  
4.6 × 50 mm). Solvent A: 100 mM TEAA (pH = 7) and solvent B: 70% ACN in 100 mM TEAA  
(pH = 7). Flow rate: 1 mL/min. Conditions: 10 min linear gradient from 0–30% B, then 5 min linear 
gradient from 30–100% B. The oligonucleotide carrying a free thiol 15 was collected and analyzed by 
mass spectrometry (MALDI-TOF). The resulting thiol oligonucleotides 15 and 18 were purified with 
Sephadex G-10 (NAP-5 column). The oligonucleotide was eluted with 1 mL of sterile water.  
Conjugation with 2-bromo-2'-hydroxy-5'-nitroacetanilide: The solution from the NAP column was 
concentrated to 500 μL and 60 μL of an aqueous solution 1 M of hydrogen carbonate (pH = 9) were 
added. Then, 100 μL of a solution 2.25 mM of 2-bromo-2'-hydroxy-5'-nitroacetanilide in DMF were 
added and allowed to react at room temperature overnight. The reaction mixtures were desalted on a 
NAP-5 column. The DNA fractions were analyzed by HPLC. The main compounds were isolated and 
analyzed by mass spectrometry. Results are summarized in Table 1. 
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Conjugation with N-(1-pyrenyl)maleimide: The solution was concentrated to 500 μL and 60 μL of 
an aqueous solution 1 M TEAA (pH = 7) were added. Then, 100 μL of a solution 2.25 mM of  
N-(1-pyrenyl)maleimide in DMF were added and allowed to react at room temperature overnight. The 
reaction mixture was desalted on a NAP-5 column. The DNA fractions were purified by HPLC.  
The main compounds were isolated and analyzed by mass spectrometry and UV/Vis spectroscopy 
(λmax = 256 and 342 nm). Results are summarized in Table 1. 
3.5. Preparation of Oligonucleotide-Gold Nanoparticle Conjugates 
Citrate stabilized gold nanoparticles (9.7 nm) were purchased from BBI Life Sciences and used as 
received. To prepare the conjugates, 5 nmol (1 OD260 unit) of disulfide modified-oligonucleotide (13 
and 14) were added to 1 mL of the gold nanoparticle solution (9.4 nM). Disulphide oligonucleotides 13 
and 14 were converted to their corresponding thiol oligonucleotides (20 and 21 respectively) by 
reaction with TCEP and as well were used to functionalize gold nanoparticles. Then, 20 nmol (4 OD260) 
of each oligonucleotide were deprotected following the conditions described above. The resulting thiol 
oligonucleotides were desalted on a NAP-5 column. Freshly deprotected oligonucleotides (5 nmol, 250 μL) 
were added to a 1 mL of gold colloid. The mixture was shaken for 16–20 h prior to salt stabilization. 
Then the solution was brought to a final concentration of 10 mM sodium phosphate (pH = 7.2). The 
mixture was then allowed to equilibrate for 30 min before bringing the concentration to 0.15 M NaCl 
over a 7 h 30 min period in a stepwise manner (0.05 M NaCl increments each 2 h 30 min). The solutions 
were sonicated for 20 s. before each addition to keep the particles dispersed during the salting 
procedure. The salting process was followed by incubation overnight at room temperature. Finally, to 
remove all unbound oligonucleotides, the solution was centrifuged at 13,200 rpm (16,100 × g) for  
30 min. The supernatant was removed and the reddish solid at the bottom of the centrifuge tube was 
dispersed in 1 mL of a 0.15 M, 10 mM sodium phosphate buffer (pH = 7.2). This procedure was 
repeated three times. Approximately 20–30% of the original nanoparticle concentration may be lost 
during centrifugation and work-up. As we wanted to compare stabilities of conjugates obtained with 
disulfide and thiol oligonucleotides (13-AuNp and 20-AuNp) disulfide and thiol oligonucleotides we 
dispersed the reddish residue in 500 μL of 0.15 M NaCl, 10 mM sodium phosphate (pH = 7.2), 0.1% 
NaN3 solution. Then, each solution was analyzed by UV-visible absorption spectroscopy and the 
concentration of gold nanoparticle conjugates was adjusted to 7.0–7.2 nM by adding the required 
volume of buffer. The conjugates obtained with the fluorescent oligonucleotides (14-AunP and  
21-AuNp) were directly resuspended in 1 mL of a 0.15 M NaCl, 10 mM sodium phosphate (pH = 7.2), 
0.1% NaN3 solution. The extinction coefficient used was the same as that used for unmodified 
nanoparticles (ε520 = 7.6 × 107 M−1cm−1, data provided by the manufacturer). Each solution was then 
stored in the fridge (4 °C) prior to use. 
3.6. Stability Tests of Oligonucleotide-Gold Nanoparticle Conjugates 
The effect of the disulphide or thiol moieties on the stability of oligonucleotide-nanoparticle 
conjugates was assessed by treating the conjugates with DTT (10 mM final concentration) at 40 °C. 
UV-vis spectra were recorded for both thiolated conjugates (13 and 20) at 1 min intervals. To give an 
indication of the durability of the oligonucleotide conjugates, absorbance at 675 nm was monitored 
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against time. Then, the half-life (time to reach half the value for complete aggregation) was calculated 
for each conjugate. 
3.7. Measuring Oligonucleotide Loading on Gold Nanoparticles 
To determine the number of oligonucleotides loaded on each particle, the concentration of 
nanoparticles and the concentration of fluorescent DNA in each sample were measured. The 
fluorescent oligonucleotides were displaced from the nanoparticle surface using DTT. Then 200 μL of 
the gold nanoparticle conjugate solution was treated with 200 μL of a 1 M DTT solution in 0.18 M 
sodium phosphate buffer, (pH = 8) at room temperature for two hours. The sample was centrifuged to 
remove the sediment from the supernatant and the fluorescence spectra was recorded (conditions:  
λEx = 495 nm and λEm = 510–550 nm). For each gold nanoparticle conjugate five different aliquots 
were prepared. Standard curves were prepared with known concentrations of the fluorescein disulfide 
oligonucleotide 14 using the same buffer, salt and DTT concentrations were prepared. The fluorescents 
values when correlated with the standard calibration curve gave a concentration for the fluorescent 
oligonucleotide in solution. The average number of oligonucleotides per particle was obtained by 
dividing the measured oligonucleotide molar concentration by the original conjugate gold nanoparticle 
concentration. Normalized surface coverage values were calculated by dividing by the surface area of 
the sphere which can be easily converted to pmol/cm2. 
3.8. Denaturation Studies 
Oligonucleotide duplexes (Table 2, entries 1–6) were dissolved in 0.3 M NaCl, 10 mM sodium 
phosphate buffer (pH = 7.0). The melting experiments were performed in duplicate at 3.5 μM 
concentration of oligonucleotide. The samples were heated at 90 °C for 5 min, allowed to cool slowly 
to room temperature to induce annealing and then kept overnight in a refrigerator at 4 °C. The melting 
curves were recorded by heating the samples with a temperature controller from 5 to 75 °C at a 
constant rate of 1 °C/min and monitoring the absorbance at 260 nm. Denaturation curves for hairpin 
oligonucleotides 11 and the corresponding unmodified hairpin were performed in duplicate at 2.8 μM 
oligonucleotide concentration in a 50 mM NaCl, 10 mM sodium phosphate buffer (pH = 7.0) (entries 7 
and 8). The melting curves were recorded by heating the samples with a temperature controller from 
20 to 85 °C at a constant rate of 1 °C/min and monitoring the absorbance at 260 nm. During the 
experiment, when the temperature was below 25 °C, argon was flushed to prevent water condensation 
on the cuvettes. The melting experiments were recorded in 1 cm path-length cells. The Tm values were 
calculated with the Meltwin 3.2 software [38]. 
4. Conclusions 
In summary, the preparation of novel monomer units for the introduction of thiol groups in 
oligonucleotides is described. The phosphoramidite derivative and functionalized solid support are 
easily prepared and allow the introduction of thiol group at terminal and internal positions of 
oligonucleotides. The monomers are made from simple and commercially available building blocks:  
L-threoninol and 3-mercaptopropionic acid. Several oligonucleotides of different lengths carrying thiol 
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groups were prepared and obtained in good yields demonstrating the utility of the novel monomer 
units. During the optimization of solid-phase synthesis protocols we observed that standard iodine 
solution is preferred to tert-butyl hydroperoxide solution and that ammonia treatment at 55 °C for 
extended time can be detrimental for the integrity of the novel thiol derivative. The use of mild 
protecting groups is recommended to minimize this last side reaction although the extension of the side 
reaction is not high. The resulting thiol-oligonucleotides react specifically and efficiently with 
molecules bearing maleimido- and bromoacetamido- groups and they can be used for the 
functionalization of gold nanoparticles. The new reagent allows the introduction of thiol group at any 
position of the sequence and, for this reason; it was possible to demonstrate the modification of gold 
nanoparticles through the reaction of the thiol group located in the middle of the oligonucleotide. 
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